跳至主要内容
临床试验/NCT04146415
NCT04146415Unknown不适用

Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera

Tel-Aviv Sourasky Medical Center0 个研究点目标入组 30 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
主要终点
Patients who preformed mTc99-PYP for cardiac amyloidosis imaging.

研究概览

简要总结

  1. Patients will undergo clinical and laboratory assessment, as well as imaging tests, at the discretion of the attending cardiologist and will be referred at their discretion to perform cardiac mapping using 99mTc-PYP.
  2. On the day of the examination, the examiner will be admitted to the Office of Nuclear Medicine and will be admitted to administrative. Before conducting the test, the subject will undergo a brief interview by a physician, receive an explanation of the study and, if agreed, sign an agreement to perform a further examination on the CZT camera.
  3. The patient will, as is customary, be installed on Vanflon 22 G periphery, through which a 15 millikiric (mCi) of

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A. Patients undergoing "cardiac amyloidosis clinic" at Tel Aviv Medical Center and there is a clinical suspicion of having cardiac amyloidosis.
  • B. Patients who performed will be referred for mapping using 99mTc-PYP and sign a consent form to take another photograph, under the cardiac-dedicated CZT camera

排除标准

  • 未提供

结局指标

主要结局

Patients who preformed mTc99-PYP for cardiac amyloidosis imaging.

时间窗: 1 year

Evaluation of cardiac amyloidosis imaging with mTc99-PYP cardiac-dedicated CZT camera

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验

Diagnosis of Cardiac Amyloidosis With 99mTc-PYP;... | 临床试验